Skin cancer of the eyelids and periorbital area produce cosmetical defects, and unlike other skin cancers they also have tendency to damage ocular and adnexal structures by direct invasion or as a result of the therapy. No matter which treatment is used the cancer should be eradicated in toto, without damaging structures and function of the eye, and as the final goal to achieve normal functional and cosmetical result.
